nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—MMP2—malignant glioma	0.307	0.398	CbGaD
Captopril—F2—malignant glioma	0.262	0.34	CbGaD
Captopril—MMP9—malignant glioma	0.202	0.262	CbGaD
Captopril—F2—vertebral column—malignant glioma	0.00569	0.0784	CbGeAlD
Captopril—REN—blood vessel—malignant glioma	0.00334	0.0461	CbGeAlD
Captopril—MMP2—endothelium—malignant glioma	0.00333	0.046	CbGeAlD
Captopril—ACE—umbilical vein—malignant glioma	0.00326	0.045	CbGeAlD
Captopril—MMP2—blood vessel—malignant glioma	0.00307	0.0424	CbGeAlD
Captopril—MMP9—endothelium—malignant glioma	0.0029	0.04	CbGeAlD
Captopril—MMP9—blood vessel—malignant glioma	0.00267	0.0369	CbGeAlD
Captopril—LTA4H—embryo—malignant glioma	0.00258	0.0356	CbGeAlD
Captopril—F2—endothelium—malignant glioma	0.00253	0.0349	CbGeAlD
Captopril—F2—blood vessel—malignant glioma	0.00233	0.0322	CbGeAlD
Captopril—LTA4H—retina—malignant glioma	0.00229	0.0315	CbGeAlD
Captopril—LTA4H—telencephalon—malignant glioma	0.0021	0.029	CbGeAlD
Captopril—Traumatic liver injury—Temozolomide—malignant glioma	0.00196	0.0554	CcSEcCtD
Captopril—MMP2—embryo—malignant glioma	0.00183	0.0253	CbGeAlD
Captopril—REN—brainstem—malignant glioma	0.00183	0.0252	CbGeAlD
Captopril—LTA4H—medulla oblongata—malignant glioma	0.00165	0.0228	CbGeAlD
Captopril—MMP2—retina—malignant glioma	0.00162	0.0224	CbGeAlD
Captopril—MMP9—embryo—malignant glioma	0.0016	0.022	CbGeAlD
Captopril—ACE—endothelium—malignant glioma	0.00155	0.0213	CbGeAlD
Captopril—LTA4H—midbrain—malignant glioma	0.00151	0.0208	CbGeAlD
Captopril—LTA4H—spinal cord—malignant glioma	0.00147	0.0203	CbGeAlD
Captopril—ACE—blood vessel—malignant glioma	0.00143	0.0197	CbGeAlD
Captopril—Myasthenia—Carmustine—malignant glioma	0.0012	0.034	CcSEcCtD
Captopril—LTA4H—central nervous system—malignant glioma	0.00119	0.0165	CbGeAlD
Captopril—MMP2—medulla oblongata—malignant glioma	0.00117	0.0162	CbGeAlD
Captopril—LTA4H—cerebellum—malignant glioma	0.00117	0.0161	CbGeAlD
Captopril—MMP2—midbrain—malignant glioma	0.00107	0.0148	CbGeAlD
Captopril—MMP2—spinal cord—malignant glioma	0.00105	0.0144	CbGeAlD
Captopril—Necrosis—Carmustine—malignant glioma	0.000962	0.0272	CcSEcCtD
Captopril—Cholestasis—Temozolomide—malignant glioma	0.000961	0.0272	CcSEcCtD
Captopril—LTA4H—brain—malignant glioma	0.000949	0.0131	CbGeAlD
Captopril—REN—central nervous system—malignant glioma	0.000922	0.0127	CbGeAlD
Captopril—MMP9—spinal cord—malignant glioma	0.000909	0.0125	CbGeAlD
Captopril—REN—cerebellum—malignant glioma	0.000901	0.0124	CbGeAlD
Captopril—Liver injury—Temozolomide—malignant glioma	0.000867	0.0245	CcSEcCtD
Captopril—ACE—embryo—malignant glioma	0.00085	0.0117	CbGeAlD
Captopril—MMP2—central nervous system—malignant glioma	0.000848	0.0117	CbGeAlD
Captopril—Drug interaction—Carmustine—malignant glioma	0.000814	0.023	CcSEcCtD
Captopril—F2—spinal cord—malignant glioma	0.000793	0.0109	CbGeAlD
Captopril—MMP9—central nervous system—malignant glioma	0.000737	0.0102	CbGeAlD
Captopril—REN—brain—malignant glioma	0.000732	0.0101	CbGeAlD
Captopril—ACE—telencephalon—malignant glioma	0.000691	0.00954	CbGeAlD
Captopril—Gynaecomastia—Carmustine—malignant glioma	0.000676	0.0191	CcSEcCtD
Captopril—Dry eye—Temozolomide—malignant glioma	0.000674	0.0191	CcSEcCtD
Captopril—MMP2—brain—malignant glioma	0.000673	0.00928	CbGeAlD
Captopril—F2—central nervous system—malignant glioma	0.000643	0.00887	CbGeAlD
Captopril—Diabetes mellitus—Carmustine—malignant glioma	0.00063	0.0178	CcSEcCtD
Captopril—MMP9—brain—malignant glioma	0.000585	0.00807	CbGeAlD
Captopril—Dermatitis exfoliative—Temozolomide—malignant glioma	0.000562	0.0159	CcSEcCtD
Captopril—Hyponatraemia—Carmustine—malignant glioma	0.000551	0.0156	CcSEcCtD
Captopril—SLC22A6—brain—malignant glioma	0.000523	0.00721	CbGeAlD
Captopril—Ataxia—Carmustine—malignant glioma	0.000516	0.0146	CcSEcCtD
Captopril—F2—brain—malignant glioma	0.000511	0.00704	CbGeAlD
Captopril—ABCB1—blood vessel—malignant glioma	0.000502	0.00692	CbGeAlD
Captopril—Ataxia—Temozolomide—malignant glioma	0.000498	0.0141	CcSEcCtD
Captopril—ACE—spinal cord—malignant glioma	0.000484	0.00668	CbGeAlD
Captopril—Muscular weakness—Carmustine—malignant glioma	0.000484	0.0137	CcSEcCtD
Captopril—Muscular weakness—Temozolomide—malignant glioma	0.000467	0.0132	CcSEcCtD
Captopril—Pancytopenia—Carmustine—malignant glioma	0.00045	0.0127	CcSEcCtD
Captopril—Neutropenia—Carmustine—malignant glioma	0.000443	0.0125	CcSEcCtD
Captopril—Pancytopenia—Temozolomide—malignant glioma	0.000435	0.0123	CcSEcCtD
Captopril—Neutropenia—Temozolomide—malignant glioma	0.000428	0.0121	CcSEcCtD
Captopril—Pollakiuria—Temozolomide—malignant glioma	0.000423	0.012	CcSEcCtD
Captopril—Erectile dysfunction—Temozolomide—malignant glioma	0.000422	0.0119	CcSEcCtD
Captopril—Photosensitivity reaction—Temozolomide—malignant glioma	0.000418	0.0118	CcSEcCtD
Captopril—Renal failure—Carmustine—malignant glioma	0.000415	0.0117	CcSEcCtD
Captopril—Weight decreased—Temozolomide—malignant glioma	0.000414	0.0117	CcSEcCtD
Captopril—Stomatitis—Carmustine—malignant glioma	0.000412	0.0116	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000405	0.0114	CcSEcCtD
Captopril—Stomatitis—Temozolomide—malignant glioma	0.000398	0.0112	CcSEcCtD
Captopril—ACE—central nervous system—malignant glioma	0.000393	0.00542	CbGeAlD
Captopril—CYP2D6—brainstem—malignant glioma	0.000381	0.00526	CbGeAlD
Captopril—Hallucination—Carmustine—malignant glioma	0.000377	0.0107	CcSEcCtD
Captopril—Hepatitis—Temozolomide—malignant glioma	0.000367	0.0104	CcSEcCtD
Captopril—Hallucination—Temozolomide—malignant glioma	0.000365	0.0103	CcSEcCtD
Captopril—Pharyngitis—Temozolomide—malignant glioma	0.000364	0.0103	CcSEcCtD
Captopril—Flushing—Carmustine—malignant glioma	0.000352	0.00995	CcSEcCtD
Captopril—Erythema multiforme—Temozolomide—malignant glioma	0.000347	0.0098	CcSEcCtD
Captopril—Flushing—Temozolomide—malignant glioma	0.00034	0.00962	CcSEcCtD
Captopril—CYP2D6—telencephalon—malignant glioma	0.000338	0.00467	CbGeAlD
Captopril—Alopecia—Carmustine—malignant glioma	0.000335	0.00947	CcSEcCtD
Captopril—ALB—brain—malignant glioma	0.000326	0.0045	CbGeAlD
Captopril—Alopecia—Temozolomide—malignant glioma	0.000324	0.00916	CcSEcCtD
Captopril—Dysgeusia—Temozolomide—malignant glioma	0.000312	0.00883	CcSEcCtD
Captopril—ACE—brain—malignant glioma	0.000312	0.0043	CbGeAlD
Captopril—Vision blurred—Carmustine—malignant glioma	0.000311	0.0088	CcSEcCtD
Captopril—Anaemia—Carmustine—malignant glioma	0.000305	0.00863	CcSEcCtD
Captopril—Vision blurred—Temozolomide—malignant glioma	0.000301	0.0085	CcSEcCtD
Captopril—ABCB1—embryo—malignant glioma	0.000299	0.00413	CbGeAlD
Captopril—Ill-defined disorder—Temozolomide—malignant glioma	0.000296	0.00837	CcSEcCtD
Captopril—Anaemia—Temozolomide—malignant glioma	0.000295	0.00834	CcSEcCtD
Captopril—Angioedema—Temozolomide—malignant glioma	0.000292	0.00824	CcSEcCtD
Captopril—Malaise—Temozolomide—malignant glioma	0.000288	0.00813	CcSEcCtD
Captopril—Palpitations—Temozolomide—malignant glioma	0.000282	0.00797	CcSEcCtD
Captopril—Myalgia—Carmustine—malignant glioma	0.000281	0.00795	CcSEcCtD
Captopril—Chest pain—Carmustine—malignant glioma	0.000281	0.00795	CcSEcCtD
Captopril—Cough—Temozolomide—malignant glioma	0.000278	0.00787	CcSEcCtD
Captopril—Confusional state—Carmustine—malignant glioma	0.000272	0.00768	CcSEcCtD
Captopril—Arthralgia—Temozolomide—malignant glioma	0.000272	0.00768	CcSEcCtD
Captopril—Myalgia—Temozolomide—malignant glioma	0.000272	0.00768	CcSEcCtD
Captopril—Discomfort—Temozolomide—malignant glioma	0.000268	0.00759	CcSEcCtD
Captopril—Dry mouth—Temozolomide—malignant glioma	0.000266	0.00751	CcSEcCtD
Captopril—ABCB1—retina—malignant glioma	0.000265	0.00365	CbGeAlD
Captopril—Thrombocytopenia—Carmustine—malignant glioma	0.000264	0.00746	CcSEcCtD
Captopril—Tachycardia—Carmustine—malignant glioma	0.000263	0.00743	CcSEcCtD
Captopril—Confusional state—Temozolomide—malignant glioma	0.000263	0.00742	CcSEcCtD
Captopril—Anaphylactic shock—Temozolomide—malignant glioma	0.00026	0.00736	CcSEcCtD
Captopril—Anorexia—Carmustine—malignant glioma	0.000257	0.00726	CcSEcCtD
Captopril—Thrombocytopenia—Temozolomide—malignant glioma	0.000255	0.00721	CcSEcCtD
Captopril—Hypotension—Carmustine—malignant glioma	0.000252	0.00712	CcSEcCtD
Captopril—Anorexia—Temozolomide—malignant glioma	0.000248	0.00702	CcSEcCtD
Captopril—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000246	0.00694	CcSEcCtD
Captopril—Insomnia—Carmustine—malignant glioma	0.000244	0.00689	CcSEcCtD
Captopril—ABCB1—telencephalon—malignant glioma	0.000243	0.00336	CbGeAlD
Captopril—Paraesthesia—Carmustine—malignant glioma	0.000242	0.00684	CcSEcCtD
Captopril—Dyspnoea—Carmustine—malignant glioma	0.00024	0.00679	CcSEcCtD
Captopril—Somnolence—Carmustine—malignant glioma	0.00024	0.00677	CcSEcCtD
Captopril—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000237	0.00671	CcSEcCtD
Captopril—Insomnia—Temozolomide—malignant glioma	0.000236	0.00666	CcSEcCtD
Captopril—Decreased appetite—Carmustine—malignant glioma	0.000234	0.00662	CcSEcCtD
Captopril—Paraesthesia—Temozolomide—malignant glioma	0.000234	0.00661	CcSEcCtD
Captopril—Dyspnoea—Temozolomide—malignant glioma	0.000232	0.00656	CcSEcCtD
Captopril—Somnolence—Temozolomide—malignant glioma	0.000232	0.00654	CcSEcCtD
Captopril—Constipation—Carmustine—malignant glioma	0.00023	0.00651	CcSEcCtD
Captopril—Dyspepsia—Temozolomide—malignant glioma	0.000229	0.00648	CcSEcCtD
Captopril—Decreased appetite—Temozolomide—malignant glioma	0.000226	0.0064	CcSEcCtD
Captopril—Fatigue—Temozolomide—malignant glioma	0.000225	0.00635	CcSEcCtD
Captopril—Constipation—Temozolomide—malignant glioma	0.000223	0.00629	CcSEcCtD
Captopril—Feeling abnormal—Carmustine—malignant glioma	0.000222	0.00628	CcSEcCtD
Captopril—Gastrointestinal pain—Carmustine—malignant glioma	0.00022	0.00623	CcSEcCtD
Captopril—Feeling abnormal—Temozolomide—malignant glioma	0.000215	0.00607	CcSEcCtD
Captopril—Body temperature increased—Carmustine—malignant glioma	0.000213	0.00602	CcSEcCtD
Captopril—Abdominal pain—Carmustine—malignant glioma	0.000213	0.00602	CcSEcCtD
Captopril—Gastrointestinal pain—Temozolomide—malignant glioma	0.000213	0.00602	CcSEcCtD
Captopril—Body temperature increased—Temozolomide—malignant glioma	0.000206	0.00582	CcSEcCtD
Captopril—Abdominal pain—Temozolomide—malignant glioma	0.000206	0.00582	CcSEcCtD
Captopril—Asthenia—Carmustine—malignant glioma	0.000193	0.00547	CcSEcCtD
Captopril—CYP2D6—central nervous system—malignant glioma	0.000192	0.00265	CbGeAlD
Captopril—ABCB1—medulla oblongata—malignant glioma	0.000191	0.00264	CbGeAlD
Captopril—CYP2D6—cerebellum—malignant glioma	0.000188	0.00259	CbGeAlD
Captopril—Asthenia—Temozolomide—malignant glioma	0.000187	0.00528	CcSEcCtD
Captopril—Diarrhoea—Carmustine—malignant glioma	0.000184	0.00521	CcSEcCtD
Captopril—Pruritus—Temozolomide—malignant glioma	0.000184	0.00521	CcSEcCtD
Captopril—Dizziness—Carmustine—malignant glioma	0.000178	0.00504	CcSEcCtD
Captopril—Diarrhoea—Temozolomide—malignant glioma	0.000178	0.00504	CcSEcCtD
Captopril—ABCB1—midbrain—malignant glioma	0.000175	0.00241	CbGeAlD
Captopril—Dizziness—Temozolomide—malignant glioma	0.000172	0.00487	CcSEcCtD
Captopril—Vomiting—Carmustine—malignant glioma	0.000171	0.00484	CcSEcCtD
Captopril—ABCB1—spinal cord—malignant glioma	0.000171	0.00235	CbGeAlD
Captopril—Rash—Carmustine—malignant glioma	0.00017	0.0048	CcSEcCtD
Captopril—Dermatitis—Carmustine—malignant glioma	0.00017	0.0048	CcSEcCtD
Captopril—Headache—Carmustine—malignant glioma	0.000169	0.00477	CcSEcCtD
Captopril—Vomiting—Temozolomide—malignant glioma	0.000166	0.00468	CcSEcCtD
Captopril—Rash—Temozolomide—malignant glioma	0.000164	0.00464	CcSEcCtD
Captopril—Dermatitis—Temozolomide—malignant glioma	0.000164	0.00464	CcSEcCtD
Captopril—Headache—Temozolomide—malignant glioma	0.000163	0.00461	CcSEcCtD
Captopril—Nausea—Carmustine—malignant glioma	0.00016	0.00452	CcSEcCtD
Captopril—Nausea—Temozolomide—malignant glioma	0.000155	0.00437	CcSEcCtD
Captopril—CYP2D6—brain—malignant glioma	0.000153	0.00211	CbGeAlD
Captopril—ABCB1—central nervous system—malignant glioma	0.000138	0.00191	CbGeAlD
Captopril—ABCB1—cerebellum—malignant glioma	0.000135	0.00186	CbGeAlD
Captopril—ABCB1—brain—malignant glioma	0.00011	0.00151	CbGeAlD
Captopril—ALB—Hemostasis—KNG1—malignant glioma	1.59e-05	0.000131	CbGpPWpGaD
Captopril—F2—Signaling Pathways—YWHAE—malignant glioma	1.59e-05	0.00013	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NTRK2—malignant glioma	1.59e-05	0.00013	CbGpPWpGaD
Captopril—ALB—Metabolism—BCAN—malignant glioma	1.59e-05	0.00013	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	1.58e-05	0.00013	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FLT1—malignant glioma	1.58e-05	0.00013	CbGpPWpGaD
Captopril—F2—Signaling Pathways—DUSP6—malignant glioma	1.58e-05	0.000129	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—PIK3CG—malignant glioma	1.57e-05	0.000129	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MMP3—malignant glioma	1.56e-05	0.000128	CbGpPWpGaD
Captopril—ALB—Hemostasis—IFNA2—malignant glioma	1.56e-05	0.000128	CbGpPWpGaD
Captopril—F2—Signaling Pathways—JAG1—malignant glioma	1.56e-05	0.000128	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—SLC5A5—malignant glioma	1.55e-05	0.000127	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NOTCH3—malignant glioma	1.55e-05	0.000127	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CDKN2B—malignant glioma	1.55e-05	0.000127	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FBXW7—malignant glioma	1.52e-05	0.000125	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	1.5e-05	0.000123	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PTK2—malignant glioma	1.5e-05	0.000123	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—RAF1—malignant glioma	1.5e-05	0.000123	CbGpPWpGaD
Captopril—F2—Signaling Pathways—BDKRB2—malignant glioma	1.49e-05	0.000123	CbGpPWpGaD
Captopril—F2—Hemostasis—VEGFA—malignant glioma	1.48e-05	0.000122	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	1.48e-05	0.000122	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ASMT—malignant glioma	1.48e-05	0.000121	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	1.48e-05	0.000121	CbGpPWpGaD
Captopril—ALB—Hemostasis—SOD1—malignant glioma	1.48e-05	0.000121	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	1.48e-05	0.000121	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—SLC6A3—malignant glioma	1.48e-05	0.000121	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HES1—malignant glioma	1.47e-05	0.000121	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NCOR1—malignant glioma	1.47e-05	0.00012	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	1.46e-05	0.00012	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	1.46e-05	0.00012	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—CXCL8—malignant glioma	1.44e-05	0.000118	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—AKT2—malignant glioma	1.43e-05	0.000118	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	1.43e-05	0.000117	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PIK3CG—malignant glioma	1.42e-05	0.000117	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PDGFRA—malignant glioma	1.4e-05	0.000115	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PTPN11—malignant glioma	1.4e-05	0.000115	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ASMT—malignant glioma	1.39e-05	0.000114	CbGpPWpGaD
Captopril—ABCB1—Metabolism—BCAN—malignant glioma	1.39e-05	0.000114	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NOTCH2—malignant glioma	1.39e-05	0.000114	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—PIK3CD—malignant glioma	1.38e-05	0.000113	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SPP1—malignant glioma	1.36e-05	0.000112	CbGpPWpGaD
Captopril—F2—Signaling Pathways—KNG1—malignant glioma	1.36e-05	0.000112	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	1.36e-05	0.000111	CbGpPWpGaD
Captopril—ALB—Hemostasis—PTK2—malignant glioma	1.36e-05	0.000111	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—IL2—malignant glioma	1.34e-05	0.00011	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	1.32e-05	0.000109	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—BCAN—malignant glioma	1.31e-05	0.000108	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—AKT2—malignant glioma	1.3e-05	0.000107	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NTRK1—malignant glioma	1.3e-05	0.000106	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	1.29e-05	0.000106	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TERT—malignant glioma	1.29e-05	0.000106	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—RAF1—malignant glioma	1.29e-05	0.000106	CbGpPWpGaD
Captopril—ALB—Metabolism—IDH2—malignant glioma	1.28e-05	0.000105	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PDGFB—malignant glioma	1.26e-05	0.000104	CbGpPWpGaD
Captopril—F2—Hemostasis—KRAS—malignant glioma	1.26e-05	0.000104	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—FGFR1—malignant glioma	1.25e-05	0.000103	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PIK3CD—malignant glioma	1.25e-05	0.000103	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—AKT1—malignant glioma	1.25e-05	0.000103	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	1.24e-05	0.000102	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HIF1A—malignant glioma	1.24e-05	0.000101	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.21e-05	9.91e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MMP3—malignant glioma	1.2e-05	9.89e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP2B6—malignant glioma	1.2e-05	9.88e-05	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—PIK3CB—malignant glioma	1.2e-05	9.86e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CAV1—malignant glioma	1.2e-05	9.82e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CDKN2B—malignant glioma	1.19e-05	9.8e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—KDR—malignant glioma	1.18e-05	9.71e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PTK2—malignant glioma	1.16e-05	9.52e-05	CbGpPWpGaD
Captopril—F2—Hemostasis—PIK3CA—malignant glioma	1.16e-05	9.51e-05	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CXCL8—malignant glioma	1.15e-05	9.48e-05	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	1.14e-05	9.37e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PDGFB—malignant glioma	1.14e-05	9.36e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HES1—malignant glioma	1.14e-05	9.35e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—FN1—malignant glioma	1.14e-05	9.34e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—F2—malignant glioma	1.14e-05	9.34e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NCOR1—malignant glioma	1.13e-05	9.3e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—BAD—malignant glioma	1.12e-05	9.23e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	1.12e-05	9.23e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—IDH2—malignant glioma	1.12e-05	9.2e-05	CbGpPWpGaD
Captopril—F2—Hemostasis—TP53—malignant glioma	1.12e-05	9.2e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—RAF1—malignant glioma	1.12e-05	9.17e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NOTCH1—malignant glioma	1.11e-05	9.14e-05	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—IL2—malignant glioma	1.1e-05	9.06e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—IDH1—malignant glioma	1.1e-05	9.03e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CD80—malignant glioma	1.09e-05	8.96e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PIK3CB—malignant glioma	1.09e-05	8.95e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PIK3CG—malignant glioma	1.09e-05	8.94e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—APC—malignant glioma	1.09e-05	8.94e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PDGFRA—malignant glioma	1.08e-05	8.9e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—CAV1—malignant glioma	1.08e-05	8.87e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—EGF—malignant glioma	1.08e-05	8.84e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PTPN11—malignant glioma	1.07e-05	8.78e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—SPHK1—malignant glioma	1.06e-05	8.74e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—IDH2—malignant glioma	1.06e-05	8.67e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP2B6—malignant glioma	1.05e-05	8.65e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SPP1—malignant glioma	1.05e-05	8.64e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CXCL8—malignant glioma	1.05e-05	8.6e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP2C18—malignant glioma	1.04e-05	8.56e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	1.03e-05	8.49e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—F2—malignant glioma	1.03e-05	8.44e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—FN1—malignant glioma	1.03e-05	8.44e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—BRAF—malignant glioma	1.02e-05	8.4e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	1.01e-05	8.31e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL2—malignant glioma	1e-05	8.22e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TERT—malignant glioma	9.98e-06	8.19e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AKT2—malignant glioma	9.96e-06	8.18e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP2B6—malignant glioma	9.93e-06	8.16e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PIK3CG—malignant glioma	9.84e-06	8.08e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	9.83e-06	8.08e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PDGFB—malignant glioma	9.74e-06	8e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—EGF—malignant glioma	9.73e-06	7.99e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FGFR1—malignant glioma	9.69e-06	7.96e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PTPN11—malignant glioma	9.67e-06	7.94e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—IDH1—malignant glioma	9.64e-06	7.92e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	9.63e-06	7.91e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PIK3CD—malignant glioma	9.57e-06	7.86e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	9.56e-06	7.85e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HIF1A—malignant glioma	9.54e-06	7.84e-05	CbGpPWpGaD
Captopril—F2—Hemostasis—AKT1—malignant glioma	9.46e-06	7.77e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SPHK1—malignant glioma	9.33e-06	7.66e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CAV1—malignant glioma	9.23e-06	7.58e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—FGF2—malignant glioma	9.17e-06	7.53e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP2C18—malignant glioma	9.14e-06	7.5e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—KDR—malignant glioma	9.13e-06	7.49e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—IDH1—malignant glioma	9.08e-06	7.46e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—AKT2—malignant glioma	9e-06	7.39e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	8.96e-06	7.36e-05	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	8.92e-06	7.32e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SPHK1—malignant glioma	8.79e-06	7.22e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FN1—malignant glioma	8.79e-06	7.21e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	8.78e-06	7.21e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—BAD—malignant glioma	8.68e-06	7.13e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PIK3CD—malignant glioma	8.65e-06	7.1e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	8.65e-06	7.1e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP2C18—malignant glioma	8.61e-06	7.07e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NOTCH1—malignant glioma	8.6e-06	7.06e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MDM2—malignant glioma	8.58e-06	7.04e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—RAF1—malignant glioma	8.55e-06	7.02e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	8.49e-06	6.97e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ERBB2—malignant glioma	8.45e-06	6.94e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GSTT1—malignant glioma	8.43e-06	6.93e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CD80—malignant glioma	8.42e-06	6.92e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—APC—malignant glioma	8.41e-06	6.9e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PIK3CG—malignant glioma	8.41e-06	6.9e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PIK3CB—malignant glioma	8.34e-06	6.85e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—EGF—malignant glioma	8.31e-06	6.82e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PTPN11—malignant glioma	8.26e-06	6.78e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CXCL8—malignant glioma	8.02e-06	6.58e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PTGS1—malignant glioma	7.9e-06	6.49e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—BRAF—malignant glioma	7.9e-06	6.49e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	7.88e-06	6.47e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—RAF1—malignant glioma	7.72e-06	6.34e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AKT2—malignant glioma	7.69e-06	6.32e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CASP3—malignant glioma	7.67e-06	6.3e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL2—malignant glioma	7.66e-06	6.29e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—EGFR—malignant glioma	7.66e-06	6.29e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PIK3CB—malignant glioma	7.54e-06	6.19e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PIK3CD—malignant glioma	7.39e-06	6.07e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GSTT1—malignant glioma	7.39e-06	6.07e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—BCHE—malignant glioma	7.35e-06	6.03e-05	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—PIK3CA—malignant glioma	7.32e-06	6.01e-05	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	7.28e-06	5.98e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—SLC5A5—malignant glioma	7.26e-06	5.96e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—KRAS—malignant glioma	7.24e-06	5.94e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PTEN—malignant glioma	7.21e-06	5.92e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	7.17e-06	5.89e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FGF2—malignant glioma	7.08e-06	5.81e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GSTT1—malignant glioma	6.96e-06	5.72e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTGS1—malignant glioma	6.93e-06	5.69e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—IL2—malignant glioma	6.92e-06	5.69e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	6.86e-06	5.64e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	6.8e-06	5.58e-05	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	6.69e-06	5.49e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PIK3CA—malignant glioma	6.65e-06	5.46e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MDM2—malignant glioma	6.62e-06	5.44e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—RAF1—malignant glioma	6.6e-06	5.42e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ERBB2—malignant glioma	6.53e-06	5.36e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTGS1—malignant glioma	6.53e-06	5.36e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—VEGFA—malignant glioma	6.51e-06	5.35e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—STAT3—malignant glioma	6.45e-06	5.29e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PIK3CB—malignant glioma	6.44e-06	5.29e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—BCHE—malignant glioma	6.44e-06	5.29e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SLC5A5—malignant glioma	6.36e-06	5.22e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CXCL8—malignant glioma	6.19e-06	5.08e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—BCHE—malignant glioma	6.07e-06	4.98e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SLC5A5—malignant glioma	5.99e-06	4.92e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MYC—malignant glioma	5.99e-06	4.92e-05	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—AKT1—malignant glioma	5.98e-06	4.91e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.93e-06	4.87e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CASP3—malignant glioma	5.93e-06	4.87e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL2—malignant glioma	5.92e-06	4.86e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—VEGFA—malignant glioma	5.88e-06	4.83e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—EGFR—malignant glioma	5.86e-06	4.81e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	5.86e-06	4.81e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GSTP1—malignant glioma	5.85e-06	4.8e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CAT—malignant glioma	5.69e-06	4.67e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MMP9—malignant glioma	5.6e-06	4.6e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PTEN—malignant glioma	5.57e-06	4.57e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—KRAS—malignant glioma	5.54e-06	4.55e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—AKT1—malignant glioma	5.43e-06	4.46e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—NCOR1—malignant glioma	5.37e-06	4.41e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GSTP1—malignant glioma	5.12e-06	4.21e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PIK3CA—malignant glioma	5.09e-06	4.18e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—VEGFA—malignant glioma	5.03e-06	4.13e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—KRAS—malignant glioma	5e-06	4.11e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CAT—malignant glioma	4.98e-06	4.09e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—STAT3—malignant glioma	4.98e-06	4.09e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TP53—malignant glioma	4.92e-06	4.04e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GSTP1—malignant glioma	4.83e-06	3.96e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NCOR1—malignant glioma	4.71e-06	3.87e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CAT—malignant glioma	4.7e-06	3.86e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MYC—malignant glioma	4.63e-06	3.8e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PIK3CA—malignant glioma	4.6e-06	3.77e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—EGFR—malignant glioma	4.52e-06	3.72e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—TP53—malignant glioma	4.45e-06	3.65e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NCOR1—malignant glioma	4.44e-06	3.64e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CAV1—malignant glioma	4.38e-06	3.6e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—KRAS—malignant glioma	4.27e-06	3.51e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.18e-06	3.44e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AKT1—malignant glioma	4.16e-06	3.41e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PIK3CG—malignant glioma	3.99e-06	3.28e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PIK3CA—malignant glioma	3.93e-06	3.22e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PPARG—malignant glioma	3.85e-06	3.16e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CAV1—malignant glioma	3.84e-06	3.15e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TP53—malignant glioma	3.8e-06	3.12e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—AKT1—malignant glioma	3.75e-06	3.08e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CAV1—malignant glioma	3.62e-06	2.97e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PIK3CD—malignant glioma	3.51e-06	2.88e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PIK3CG—malignant glioma	3.5e-06	2.87e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PPARG—malignant glioma	3.37e-06	2.77e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PIK3CG—malignant glioma	3.29e-06	2.7e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AKT1—malignant glioma	3.21e-06	2.63e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PPARG—malignant glioma	3.18e-06	2.61e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PIK3CD—malignant glioma	3.07e-06	2.52e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PIK3CB—malignant glioma	3.06e-06	2.51e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PTGS2—malignant glioma	3.03e-06	2.49e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PIK3CD—malignant glioma	2.9e-06	2.38e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PIK3CB—malignant glioma	2.68e-06	2.2e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTGS2—malignant glioma	2.65e-06	2.18e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PTEN—malignant glioma	2.64e-06	2.17e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PIK3CB—malignant glioma	2.52e-06	2.07e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTGS2—malignant glioma	2.5e-06	2.05e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTEN—malignant glioma	2.31e-06	1.9e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTEN—malignant glioma	2.18e-06	1.79e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PIK3CA—malignant glioma	1.86e-06	1.53e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PIK3CA—malignant glioma	1.63e-06	1.34e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.54e-06	1.26e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—AKT1—malignant glioma	1.52e-06	1.25e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—AKT1—malignant glioma	1.33e-06	1.1e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—AKT1—malignant glioma	1.26e-06	1.03e-05	CbGpPWpGaD
